|Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array|
RA Eeles, AA Al Olama, S Benlloch, EJ Saunders, DA Leongamornlert, ...
Nature genetics 45 (4), 385, 2013
|Identification of seven new prostate cancer susceptibility loci through a genome-wide association study|
RA Eeles, Z Kote-Jarai, AA Al Olama, GG Giles, M Guy, G Severi, K Muir, ...
Nature genetics 41 (10), 1116, 2009
|Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study|
Z Kote-Jarai, AA Al Olama, GG Giles, G Severi, J Schleutker, M Weischer, ...
Nature genetics 43 (8), 785, 2011
|Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer|
LM FitzGerald, I Agalliu, K Johnson, MA Miller, EM Kwon, A Hurtado-Coll, ...
BMC cancer 8 (1), 230, 2008
|Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study|
Y Zhu, RG Stevens, AE Hoffman, LM FitzGerald, EM Kwon, EA Ostrander, ...
Cancer research 69 (24), 9315-9322, 2009
|The OncoArray Consortium: a network for understanding the genetic architecture of common cancers|
CI Amos, J Dennis, Z Wang, J Byun, FR Schumacher, SA Gayther, ...
Cancer Epidemiology and Prevention Biomarkers 26 (1), 126-135, 2017
|A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease|
A Amin Al Olama, Z Kote-Jarai, FR Schumacher, F Wiklund, SI Berndt, ...
Human molecular genetics 22 (2), 408-415, 2012
|Mutations in a novel gene, NHS, cause the pleiotropic effects of Nance-Horan syndrome, including severe congenital cataract, dental anomalies, and mental retardation|
KP Burdon, JD McKay, MM Sale, IM Russell-Eggitt, DA Mackey, MG Wirth, ...
The American Journal of Human Genetics 73 (5), 1120-1130, 2003
|Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci|
FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ...
Nature genetics 50 (7), 928, 2018
|Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer risk|
CA Salinas, EM Kwon, LM FitzGerald, Z Feng, PS Nelson, EA Ostrander, ...
American journal of epidemiology 172 (5), 578-590, 2010
|Clinical utility of five genetic variants for predicting prostate cancer risk and mortality|
CA Salinas, JS Koopmeiners, EM Kwon, L FitzGerald, DW Lin, ...
The prostate 69 (4), 363-372, 2009
|Mutations in the NDP gene: contribution to Norrie disease, familial exudative vitreoretinopathy and retinopathy of prematurity|
JL Dickinson, MM Sale, A Passmore, LM FitzGerald, CM Wheatley, ...
Clinical & experimental ophthalmology 34 (7), 682-688, 2006
|Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality|
DW Lin, LM FitzGerald, R Fu, EM Kwon, SL Zheng, S Kolb, F Wiklund, ...
Cancer Epidemiology and Prevention Biomarkers 20 (9), 1928-1936, 2011
|Genome-wide meta-analyses of breast, ovarian, and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types|
SP Kar, J Beesley, AA Al Olama, K Michailidou, J Tyrer, ZS Kote-Jarai, ...
Cancer discovery 6 (9), 1052-1067, 2016
|Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype?|
T Dwyer, JM Stankovich, L Blizzard, LM FitzGerald, JL Dickinson, A Reilly, ...
American journal of epidemiology 159 (9), 826-833, 2004
|Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features|
LM FitzGerald, EM Kwon, JS Koopmeiners, CA Salinas, JL Stanford, ...
Clinical Cancer Research 15 (9), 3231-3237, 2009
|Genome-wide association study identifies a genetic variant associated with risk for more aggressive prostate cancer|
LM FitzGerald, EM Kwon, MP Conomos, S Kolb, SK Holt, D Levine, ...
Cancer Epidemiology and Prevention Biomarkers 20 (6), 1196-1203, 2011
|Risk analysis of prostate cancer in PRACTICAL, a multinational consortium, using 25 known prostate cancer susceptibility loci|
AA Al Olama, S Benlloch, AC Antoniou, GG Giles, G Severi, DE Neal, ...
Cancer Epidemiology and Prevention Biomarkers 24 (7), 1121-1129, 2015
|Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans|
A Amin Al Olama, T Dadaev, DJ Hazelett, Q Li, D Leongamornlert, ...
Human molecular genetics 24 (19), 5589-5602, 2015
|Effect of MELANOTAN®,[Nle4, D-Phe7]-α-MSH, on melanin synthesis in humans with MC1R variant alleles|
LM FitzGerald, JL Fryer, T Dwyer, SM Humphrey
Peptides 27 (2), 388-394, 2006